BIOXCEL THERAPEUTICS INC
BTAI stock holders 13F
1 superinvestor reported owning BTAI (Common Stock) according to the gurus' latest report.
Top gurus who own (BTAI) BIOXCEL THERAPEUTICS INC
The 1 super investor (holders) owning BTAI (by the percentage (%) of portfolio) is Howard Marks - Oaktree Capital Management (0.01%) as of the latest report.
To check the latest activities of the top BTAI shareholders between value investors, please click on the "Activity" tab.
To see the historical data of BTAI's holders please click on the "HOLDING" dropdown menu and select the date.
Current price: $4.75 162.43%
2025 Q2 Reported hold price*: $1.81
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.